The discovery of the FOS retroviral homologue (v‐fos) as an initiator of osteosarcoma in mice [1] spurred significant interest in the role of FOS and its paralogues in the pathogenesis of bone and other tumours. The gene discussed is FOS; the disease is neoplasm.